Providing clinicians with quantitative & object measurements to improve patients suffering from mental illnesses with FDA-cleared brain mapping technology $AIFF
Are you experiencing intrusive thoughts and flashbacks, nightmares related to trauma, or emotional or physical distress?
Screening for #PTSD with #NeuroTechnology#QEEG is the most efficient and effective way to identify this.
https://t.co/48CJDSInzu
🧠 June is PTSD Awareness Month — and June 27 is National PTSD Awareness Day.
PTSD is real, measurable, and treatable. How are you integrating objective brain data into PTSD research or care today?
Not every patient who looks like ADHD has ADHD.
Poor focus, inattention, and cognitive slowing can also be associated with:
🧠 Depression
🧠 PTSD
🧠 Sleep Disorders
🧠 Anxiety
The challenge isn't identifying the symptoms.
It's identifying what's causing them.
#FireflyNeuro
Brain health is entering the AI era.
Firefly's AI-driven Evoke platform is helping transform brain assessment from subjective observation to measurable insight.
Read the announcement below.
https://t.co/ezEPW3aYBa
#FireflyNeuro#NeuroTechnology#EEG
AAN moves fast.
If you’re evaluating new approaches to brain measurement, don’t leave it to chance conversations.
Schedule time with us now: https://t.co/2U0o6NeRky
At the end of treatment, the question is: What actually changed?
EEG allows clinicians to compare post-treatment brain activity to baseline. This moves evaluation beyond symptoms to measurable change.
#EEG#ClinicalDecisionMaking#BrainHealth#FireflyNeuro
Once treatment is underway, the key question becomes: Is this working?
EEG can be used during care to assess whether brain function is changing. This provides data to evaluate direction, not just patient-reported improvement.
#EEG#ClinicalCare#BrainMeasurement#FireflyNeuro
Before treatment begins, the most important question is: What are we starting from?
EEG can be used to establish a functional baseline of brain activity prior to intervention.
Without a baseline, progress is judged by symptoms alone.
#EEG#BrainHealth#FireflyNeuro
Firefly Neuroscience, Inc. announced new progress using AI-powered EEG and ERP brain scans to help distinguish between the three primary ADHD subtypes.
Read the announcement below.
https://t.co/hkbaguBZnq
#FireflyNeuro#BrainHealth
The Firefly platform adds a functional data layer through EEG & ERP—supporting:
✔ More informed clinical assessment
✔ Clearer evaluation of treatment impact
✔ Greater confidence in next-step and referral decisions
Schedule a demo at: https://t.co/I5IddG2EEr
#CognitiveCare
Instead of relying on overlapping presentations, Our Evoke system shows the functional signature behind the symptoms — helping reduce misdiagnosis and guide more precise care.
#CognitiveElectrophysiology#ClinicalConfidence
🧠 Chronological age tells us time — but “brain age” tells us function.
By tracking deviations in estimated brain age over time, clinicians can monitor disease progression, evaluate treatment effects, and better understand the brain’s trajectory.
#CognitiveBiomarkers
🇺🇸 Honoring Those Who Serve
On Veterans Day, we pause to recognize the courage and sacrifice of those who’ve served — and to reaffirm our commitment to supporting their ongoing health.
To every veteran & their family: thank you for your service, resilience, and strength.
Alzheimer’s, dementia, & other neurocognitive disorders each impact the brain differently — early functional changes appear before symptoms.
Firefly helps clinicians distinguish subtle disruptions in brain processing, supporting earlier, more precise diagnosis & care planning.
💡 Progress begins with clarity.
At Firefly, we’re proud to support clinicians and researchers who are illuminating how the brain changes in Alzheimer’s and related conditions.
#AlzheimersAwareness